Notice Type
Departmental
Notice Title

Notice of Application to Register a Trade Name Product (Notice No. 81)

Pursuant to section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997, the Director-General
of the New Zealand Food Safety Authority gives notice
that the following application has been made to register a trade name product under section 9(1) of the Agricultural Compounds and Veterinary Medicines Act 1997:
Trade Name: EXCEDE LA Sterile Suspension
Reference: A010150
Active Ingredient and Concentration: Cettiofur as the crystalline free acid 200mg/mL (200g/L)
Formulation Type: Sterile suspension
General Use Claims: EXCEDE LA Sterile Suspension
is indicated for treatment of the following bacterial diseases:
Bovine respiratory disease (BRD) associated
with Mannheimia (Pasteurella) haemolytica, Pasteurella multocida and Histophilus somni (Haemophilus somnus).
Bovine interdigital necrobacillosis (foot rot) associated with Fusobacterium necrophorum and Porphyromonas (Bacteroides) Levii.
Any person may make a written submission to the
director-general concerning this application. Under sections 16 and 17 of the Agricultural Compounds and Veterinary Medicines Act 1997, a written submission:
(a) must state in full the reasons for making the submission; and
(b) may state any decision sought on that application; and
(c) must be received by the director-general no later than 30 working days after the date of notification
in the New Zealand Gazette.
A copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
(a) where submissions on this application are to be sent; and
(b) where requests for copies of the public information relating to the application can be sent; and
(c) where public information relating to the application can be viewed; and
(d) the director-general’s address for service:
ACVM Group, New Zealand Food Safety
Authority, Level 5, South Tower, 68–86 Jervois Quay, Wellington 6011. Postal Address: PO Box 2835, Wellington 6140.
The applicant’s address for service is:
Karen Booth, c/o Pfizer New Zealand Limited, Pfizer House, Level 3, 14 Normanby Road, Mt Eden, Auckland. Postal Address: C/o Karen Booth, PO Box 3998, Shortland Street, Auckland 1140.
Dated at Wellington this 26th day of June 2008.
MAREE ZINZLEY, Programme Manager (Operations) (acting under delegated authority).